Company / Operating Income per Share
GYRE THERAPEUTICS, INC. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$0.13
FY2025
5-year range
-$3.98 / $0.21
FY2021-FY2025
Trend
-36.9%
vs FY2024
Sector context
#53 of 201
Health Care
What the data says
At $0.13, GYRE THERAPEUTICS, INC.'s operating income per share ranks #53 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-26.20 in FY2016 to $0.21 in FY2024.
Based on SEC 10-K filings.
0.13 in FY2025 with a 3-year CAGR of +3.1%.
Declined from $0.14 to $0.13 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#53 of 201 in Health CareTop 26% of 201This company $0.13 Sector average -$3.23
▼
+104.1% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 36.9% year-over-year.
- Ranks #53 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2024.
- Lowest operating income per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.13 | -36.9% |
| FY2024 | $0.21 | +45.8% |
| FY2023 | $0.14 | +19.0% |
| FY2022 | $0.12 | +103.1% |
| FY2021 | -$3.98 | +16.4% |
| FY2020 | -$4.76 | +0.7% |
| FY2019 | -$4.79 | -33.5% |
| FY2018 | -$3.59 | +43.7% |
| FY2017 | -$6.37 | +75.7% |
| FY2016 | -$26.20 | +43.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026